Development of Quality Risk Management framework for the supply of Misoprostol to Sub Saharan African Region
Suppressing maternal mortality in Sub Saharan African Region
Development of Quality Risk Management framework for the supply of Misoprostol to Sub Saharan African Region
Project Overview
The CIFF Misoprostol Project was funded by the Children’s Investment Fund Foundation (CIFF) through Population Services International (PSI) and implemented in partnership with FHI 360, academic institutions, and subject-matter experts across Africa and the United States.
Misoprostol is a life-saving medicine used in the prevention and management of postpartum hemorrhage (PPH), a leading cause of maternal mortality in the region. Variability in manufacturing standards, impurity profiles, and regulatory frameworks has historically made quality assurance complex and costly.
Key Outcomes Achieved
Reach Us Today!
Every conversation is the beginning of a partnership that strengthens systems, improves lives, and builds continental resilience.
Impact Stories
